Canine Lymphoma

A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The study resulted from a collaboration between The University of Texas MD Anderson Children’s Cancer Hospital in Houston and Texas A&M University College of Veterinary Medicine in College Station.

seeMedical News

Epstein Barr type virus and Lymphoma in Dogs

A team of researchers from the University of Pennsylvania School of Veterinary Medicine and Penn’s Perelman School of Medicine has the first evidence that an Epstein Barr-like virus can infect and may also be responsible for causing lymphomas in man’s best friend.
Dogs develop lymphomas that share some characteristics with the human equivalents. These conditions are relatively common in certain breeds. In golden retrievers, for instance, one out of every eight dogs develops lymphoma. Read the entire article at Medical News.

Canine Lymphoma treatment

02.23.12
Texas A&M , UT MD Anderson Team Up to Treat Canine Lymphoma

HOUSTON – A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the journal Scientific Reports. The study resulted from a collaboration between The University of Texas MD Anderson Children’s Cancer Hospital in Houston and Texas A&M University College of Veterinary Medicine in College Station. Continue reading Canine Lymphoma treatment

Penn Researchers : Non-Hodgkin’s Lymphoma Vaccine

October 18, 2011
PHILADELPHIA — An experimental vaccine developed by researchers at the University of Pennsylvania’s schools of Medicine and Veterinary Medicine is the first veterinary cancer vaccine of its kind that shows an increase in survival time for dogs with spontaneous non-Hodgkin’s lymphoma. The work shows for the first time the feasibility and therapeutic efficacy of this alternative cell-based vaccine, which could be employed in the treatment of a number of different cancer types.
The research was conducted by Nicola Mason, assistant professor of medicine at Penn Vet; Robert H. Vonderheide, associate professor of hematology and oncology at the Perelman School of Medicine; and Karin U. Sorenmo, associate professor of oncology at Penn Vet. Erika Krick, Beth Overley and Thomas P. Gregor of Penn Vet and Christina M. Coughlin of the School of Medicine also contributed to the research.
Their work was published in the open access journal PLOS ONE. Continue reading Penn Researchers : Non-Hodgkin’s Lymphoma Vaccine

Lymphoma Drug Shrinks Tumors In Dogs

Medical News Today Lymphoma Drug Shrinks Tumors In Dogs, Could Lead To Human Treatment
18 Jul 2011

There are many kinds of cancers of the immune system, but one, Activated B-Cell Diffuse Large B-Cell Lymphoma, or ABC-DLBCL, is particularly common and pernicious. Researchers at the University of Pennsylvania’s School of Veterinary Medicine have shown for the first time that dogs that develop this disease spontaneously share the same aberrant activation of a critical intracellular pathway with humans. They also found that a drug designed to disrupt this pathway helps to kill tumor cells in the dogs’ cancerous lymph nodes.
Continue reading Lymphoma Drug Shrinks Tumors In Dogs

Bone Marrow Transplant in Dog

Veterinary Specialty Hospital Success With Its First Bone Marrow Transplant In Dog With Lymphoma

Veterinary Specialty Hospital of San Diego (VSH) has successfully performed a hematopoietic cell transplant (better known as bone marrow transplant) for a dog with lymphoma. Cody, an otherwise active and healthy 7-year old male Golden Retriever completed his treatment and is thriving with no complications 4 months after his discharge from the hospital. Continue reading Bone Marrow Transplant in Dog